Galapagos

About Galapagos

Galapagos is a biotechnology company committed to improving the lives of people with serious diseases through life-changing science and innovation, with a focus on pioneering for patients.

Products & Services

Pipeline and Clinical Trials:Development of innovative therapies for serious diseases, as highlighted in their pipeline and clinical trial programs.

GLPG3667:A selective TYK2 inhibitor being studied for dermatomyositis and systemic lupus erythematosus, with promising Phase 3-enabling study results.

GLPG5101:A cell therapy product showing high complete response rates and durable responses in high-risk mantle cell lymphoma (MCL).

Specialties

Development of therapies for serious diseases Cell therapy TYK2 inhibitors Clinical trials and innovation in disease treatment

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Equity Financing via Subscription Rights T: - FT: Equity Financing via Subscription Rights	A: 1769850 MR: - FA: 1,769,850.00 FAN: 1769850	D: 2023-03-20 FD: 2023-03-20	1 investors
2	RT: Subscription Rights Exercise T: - FT: Subscription Rights Exercise	A: 1769850 MR: - FA: 1,769,850.00 FAN: 1769850	D: 2023-03-20 FD: 2023-03-20	1 investors

Equity Financing via Subscription Rights Latest

2023-03-20

$1.8M

1 investor (Pro only)

Subscription Rights Exercise 2023-03-20

$1.8M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

G

Glenn Schulman

Head of Investor Relations

L

Liesbeth Verstraeten

Director, Reporting & Sustainability Lead

S

Scott Brun

Venture Partner at Abingworth

LinkedIn (Pro only)

R

Rob Lenz

Executive Vice President and Head of R&D

E

Elaine Sorg

Senior Advisor at BCG

N

Nancy Valente

MD

View 24 more team members with Pro

Unlock Full Team Directory

Recent News

Galapagos Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised